219
Views
7
CrossRef citations to date
0
Altmetric
Irritable Bowel Syndrome

Seroreactivity to E. coli outer membrane protein C antibodies in active inflammatory bowel disease; diagnostic value and correlation with phylogroup B2 E. coli infection

, , , , , , & show all
Pages 155-161 | Received 08 Aug 2011, Accepted 06 Nov 2011, Published online: 08 Dec 2011

References

  • Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962–87: a sixfold increase in incidence. Scand J Gastroenterol 1992;27:609–14.
  • Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3–11.
  • Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991;100:1590–6.
  • Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992;33:657–62.
  • Colombel JF, Reumaux D, Duthilleul P, Noël LH, Gower-Rousseau C, Paris JC, Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol 1992;16:656–60.
  • Bansi DS, Chapman RW, Fleming KA. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996;8:881–5.
  • Main J, McKenzie H, Yeaman GR, Kerr MA, Robson D, Pennington CR, Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease. BMJ 1988;297:1105–6.
  • Sendid B, Colombel JF, Jacquinot PM, Faille C, Fruit J, Cortot A, Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 1996;3:219–26.
  • Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J, Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000;46:58–63.
  • Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 2004;99:2376–84.
  • Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A, Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol 2004;99:2235–41.
  • Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002;123:689–99.
  • Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998;115:1405–13.
  • Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004;127:412–21.
  • Kotlowski R, Bernstein CN, Sepehri S, Krause DO. High prevalence of Escherichia coli belonging to the B2+D phylogentic group in inflammatory bowel disease. Gut 2007;56:669–75.
  • Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis 2007;13:984–92.
  • Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papadakis KA, Taylor KD, Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004;126:414–24.
  • Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005;54:1232–6.
  • Desir B, Amre DK, Lu SE, Ohman-Strickland P, Dubinsky M, Fisher R, Utility of serum antibodies in determining clinical course in pediatric Crohn's disease. Clin Gastroenterol Hepatol 2004;2:139–46.
  • Petersen AM, Nielsen EM, Litrup E, Brynskov J, Mirsepasi H, Krogfelt KA. A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease. BMC Microbiol 2009;9:171.
  • Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514.
  • Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998;43:29–32.
  • Shen B, Achkar JP, Connor JT, Ormsby AH, Remzi FH, Bevins CL, Modified pouchitis disease activity index, a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003;46:748–53.
  • Hertervig E, Wieslander J, Johansson C, Wiik A, Nilsson A. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand J Gastroenterol 1995;30:693–8.
  • Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002;123:689–99.
  • Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007;56:1394–403.
  • Blom M, Meyer A, Gerner-Smidt P, Gaarslev K, Espersen F. Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. J Clin Microbiol 1999;37:2312–16.
  • Kjaeldgaard P, Nissen B, Lange N, Laursen H. Evaluation of Minibact, a new system for rapid identification of Enterobacteriaceae: comparison of Minibact, Micro-ID, and API 20E with a conventional method as reference. Acta Pathol Microbiol Immunol Scand 1986;94:57–61.
  • Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555–8.
  • Bélard E, Semb S, Ruhwald M, Werlinrud AM, Soborg B, Jensen FK, Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm Bowel Dis 2011;17:2340–9.
  • Teml A, Kratzer V, Schneider B, Lochs H, Norman GL, Gangl A, Anti-Sacchoromyces cerevisiae antibodies: a stable marker for Crohns's disease during steroid and 5-aminosaliclic acid tretamen. Am J Gastroenterol 2003;98:2226–31.
  • Mow WS. High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot sutdy. Dig Dis Sci 2004;49:1280–6.
  • Henckaerts L, Pierik M, Joossens M, Ferrante M, Rutgeerts P, Vermeire S. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut 2007;56:1536–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.